Using Accelerator Mass Spectrometry in Clinical Pharmacology
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Unfollow podcast failed
Using Accelerator Mass Spectrometry in Clinical Pharmacology
-
Narrated by:
-
By:
This episode is an interview with Dr. Wouter Vaes, the Chief Science Officer of Peregrion. We discuss how accelerator mass spectrometry is being used in early clinical development for drug metabolism and pharmacokinetics. We discuss using this technology to support development of oncology agents, determining absolute bioavailability without IV toxicology work, and more.
Links discussed in the show:
- You can contact Wouter by email: wouter.vaes@peregrion.com
- Connect with Peregrion on LinkedIn or their website
- Symposium on microtracer studies
- FDA guidance on safety testing of drug metabolites
- White paper on human ADME data
- You can connect with Nathan on LinkedIn and send me a message
- Send Nathan a message
- Sign up for Nathan’s newsletter
Copyright Teuscher Solutions LLC
All Rights Reserved
adbl_web_anon_alc_button_suppression_t1
No reviews yet